Fujian Aonong Biological Technology Group Incorporation (603363.SH) has announced a projected net profit of 500 million to 700 million in the year 2024, turning losses into profits.

Fujian Aonong Biological Technology Group Incorporation (603363.SH) announced its annual performance forecast for the year 2024. The company expects to achieve a net profit attributable to shareholders of the listed company of 500 million to 700 million RMB in 2024, a turnaround from a loss compared to the same period last year. It is also anticipated that the company will incur a net loss of 1.2 billion to 1.7 billion RMB after deducting non-recurring gains and losses in 2024, continuing to be in loss compared to the same period last year.